ArticleActa neurochirurgica2022

Dabrafenib monotherapy for a recurrent BRAFV600E-mutated TTF-1-positive posterior pituitary tumor.

Flavie Grenier-Chartrand et al.PubMed ↗Publisher ↗

No numbers read from the abstract.